Cubic Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $7.23M | Sell |
39,689
-71
| -0.2% | -$12.2K | 1.71% | 12 |
|
|
2023
Q4 | $6.16M | Sell |
39,760
-342
| -0.9% | -$49.9K | 1.58% | 15 |
|
|
2023
Q3 | $5.98M | Sell |
40,102
-4,700
| -10% | -$690K | 1.64% | 13 |
|
|
2023
Q2 | $6.04M | Sell |
44,802
-2,065
| -4% | -$303K | 1.62% | 19 |
|
|
2023
Q1 | $7.47M | Sell |
46,867
-737
| -2% | -$113K | 2.09% | 7 |
|
|
2022
Q4 | $7.69M | Sell |
47,604
-734
| -2% | -$113K | 2.2% | 11 |
|
|
2022
Q3 | $6.49M | Sell |
48,338
-136
| -0.3% | -$19.5K | 1.93% | 12 |
|
|
2022
Q2 | $7.42M | Sell |
48,474
-257
| -0.5% | -$39.3K | 2% | 11 |
|
|
2022
Q1 | $7.9M | Sell |
48,731
-323
| -0.7% | -$46.9K | 1.84% | 10 |
|
|
2021
Q4 | $6.64M | Buy |
49,054
+14
| +0% | +$1.65K | 1.5% | 19 |
|
|
2021
Q3 | $5.29M | Sell |
49,040
-200
| -0.4% | -$22.9K | 1.31% | 22 |
|
|
2021
Q2 | $5.55M | Buy |
49,240
+84
| +0.2% | +$9.46K | 1.37% | 21 |
|
|
2021
Q1 | $5.32M | Sell |
49,156
-900
| -2% | -$96.3K | 1.4% | 22 |
|
|
2020
Q4 | $5.36M | Buy |
50,056
+550
| +1% | +$52.9K | 1.59% | 18 |
|
|
2020
Q3 | $4.34M | Buy |
49,506
+1,939
| +4% | +$183K | 1.56% | 19 |
|
|
2020
Q2 | $4.67M | Sell |
47,567
-345
| -0.7% | -$30.4K | 1.67% | 16 |
|
|
2020
Q1 | $3.65M | Sell |
47,912
-395
| -0.8% | -$33.6K | 1.48% | 23 |
|
|
2019
Q4 | $4.28M | Buy |
48,307
+5,001
| +12% | +$415K | 1.21% | 30 |
|
|
2019
Q3 | $3.28M | Buy |
43,306
+1,018
| +2% | +$69.8K | 0.98% | 38 |
|
|
2019
Q2 | $3.08M | Buy |
42,288
+315
| +0.8% | +$24.8K | 0.92% | 41 |
|
|
2019
Q1 | $3.38M | Buy |
41,973
+1,614
| +4% | +$132K | 1% | 41 |
|
|
2018
Q4 | $3.72M | Sell |
40,359
-1,716
| -4% | -$151K | 1.22% | 33 |
|
|
2018
Q3 | $3.98M | Sell |
42,075
-710
| -2% | -$67.3K | 1.09% | 34 |
|
|
2018
Q2 | $3.96M | Sell |
42,785
-1,020
| -2% | -$99.6K | 1.15% | 31 |
|
|
2018
Q1 | $4.15M | Sell |
43,805
-230
| -0.5% | -$25.3K | 1.17% | 31 |
|
|
2017
Q4 | $4.26M | Sell |
44,035
-1,225
| -3% | -$115K | 1.19% | 32 |
|
|
2017
Q3 | $4.02M | Sell |
45,260
-595
| -1% | -$45.3K | 1.13% | 31 |
|
|
2017
Q2 | $3.33M | Buy |
45,855
+1,175
| +3% | +$79K | 0.97% | 36 |
|
|
2017
Q1 | $2.91M | Buy |
44,680
+885
| +2% | +$55.6K | 0.89% | 39 |
|
|
2016
Q4 | $2.74M | Hold |
43,795
| – | – | 0.85% | 40 |
|
|
2016
Q3 | $2.76M | Buy |
43,795
+350
| +0.8% | +$22.7K | 0.89% | 42 |
|
|
2016
Q2 | $2.69M | Sell |
43,445
-1,245
| -3% | -$75.9K | 0.91% | 41 |
|
|
2016
Q1 | $2.55M | Buy |
44,690
+980
| +2% | +$54.6K | 0.86% | 44 |
|
|
2015
Q4 | $2.59M | Buy |
43,710
+4,510
| +12% | +$260K | 0.9% | 42 |
|
|
2015
Q3 | $2.13M | Buy |
39,200
+3,030
| +8% | +$197K | 0.76% | 53 |
|
|
2015
Q2 | $2.43M | Sell |
36,170
-413
| -1% | -$27K | 0.77% | 52 |
|
|
2015
Q1 | $2.14M | Sell |
36,583
-345
| -0.9% | -$20.8K | 0.69% | 56 |
|
|
2014
Q4 | $2.42M | Sell |
36,928
-152
| -0.4% | -$9.58K | 0.78% | 47 |
|
|
2014
Q3 | $2.14M | Sell |
37,080
-550
| -1% | -$30.5K | 0.75% | 50 |
|
|
2014
Q2 | $2.12M | Sell |
37,630
-535
| -1% | -$28.1K | 0.7% | 56 |
|
|
2014
Q1 | $1.96M | Buy |
38,165
+50
| +0.1% | +$2.53K | 0.68% | 58 |
|
|
2013
Q4 | $2.01M | Buy |
38,115
+100
| +0.3% | +$4.92K | 0.63% | 66 |
|
|
2013
Q3 | $1.7M | Sell |
38,015
-300
| -0.8% | -$13.3K | 0.55% | 76 |
|
|
2013
Q2 | $1.58M | Buy |
+38,315
| New | +$1.68M | 0.55% | 71 |
|
Other funds holding ABBV
Cubic Asset Management's ABBV Position: Q1 2024 in Review
Cubic Asset Management reduced its AbbVie (ABBV) stake by 0.18% in Q1 2024, selling an estimated $12.2K and leaving 39,689 shares worth $7.23M. The position accounts for 1.71% of the portfolio, ranked #12.
Cubic Asset Management first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $7.9M in Q1 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Cubic Asset Management held 39,689 shares of AbbVie worth $7.23M as of Q1 2024.
- Cubic Asset Management sold 71 AbbVie shares in Q1 2024, an estimated $12.2K.
- AbbVie made up 1.71% of Cubic Asset Management's portfolio in Q1 2024, its #12 holding.
- Cubic Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
- Cubic Asset Management's AbbVie position peaked at $7.9M in Q1 2022.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.